Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shimoyama

Showing results (1-10 of 399) with videos related to

Pageof 40
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2000
[Prognostic factors and predictive model of non-Hodgkin's lymphoma: pathological prognostic groupings and international prognostic index]M Shimoyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 10, 1996
[Drug therapy of hematologic malignancy]M Shimoyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1988
[Recent progress in non-Hodgkin's lymphoma study in Japan]M Shimoyama
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 1, 1976
[Drug sensitivity of cultured human cancer cell lines (author's transl)]M Shimoyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1983
[Malignant lymphoma--recent progress in diagnosis and treatment. 2. Application of recent diagnostic analysis. (1). Cellular origin of non-Hodgkin's lymphoma]M Shimoyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 1, 1989
[Major prognostic factors in patients with T- and B-cell lymphomas]M Shimoyama
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1985
Monoclonal antibodies and immunodiagnosis of leukemia/lymphomaM Shimoyama
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|October 1, 1974
[Strategy of antileukemic agents; the relationship between in vitro cell-killing kinetics and in vivo chemotherapeutic effects (author's transl)]M Shimoyama
Seikagaku. the Journal of Japanese Biochemical Society|February 1, 1991
[Endogenous arginine-specific ADP-ribosyltransferases and their target proteins]M Shimoyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 10, 1994
[Prognostic factors and predictive model of malignant lymphoma]M Shimoyama
Pageof 40

Showing results (1-10 of 399) with videos related to

Sort By:
Pageof 40
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2000
[Prognostic factors and predictive model of non-Hodgkin's lymphoma: pathological prognostic groupings and international prognostic index]M Shimoyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 10, 1996
[Drug therapy of hematologic malignancy]M Shimoyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1988
[Recent progress in non-Hodgkin's lymphoma study in Japan]M Shimoyama
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 1, 1976
[Drug sensitivity of cultured human cancer cell lines (author's transl)]M Shimoyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1983
[Malignant lymphoma--recent progress in diagnosis and treatment. 2. Application of recent diagnostic analysis. (1). Cellular origin of non-Hodgkin's lymphoma]M Shimoyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 1, 1989
[Major prognostic factors in patients with T- and B-cell lymphomas]M Shimoyama
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1985
Monoclonal antibodies and immunodiagnosis of leukemia/lymphomaM Shimoyama
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|October 1, 1974
[Strategy of antileukemic agents; the relationship between in vitro cell-killing kinetics and in vivo chemotherapeutic effects (author's transl)]M Shimoyama
Seikagaku. the Journal of Japanese Biochemical Society|February 1, 1991
[Endogenous arginine-specific ADP-ribosyltransferases and their target proteins]M Shimoyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 10, 1994
[Prognostic factors and predictive model of malignant lymphoma]M Shimoyama
Pageof 40